The rising incidence of skin cancer and its associated mortality, deformity, and medical costs represent a major public health concern. There is a pressing need for a better understanding of the molecular basis for what triggers incipient cancer cells to develop into tumors. We have demonstrated that polyamines play an essential role in the early promotional phase of skin tumorigenesis by activating not only epithelial cells but also underlying stromal cells. Ornithine decarboxylase (ODC) is a key regulatory enzyme in the biosynthesis of polyamines, which are essential for normal cell growth and differentiation. De novo induction of ODC activity in the suprabasal epidermis produces a phenotype similar to that in wounded skin, with stimulated proliferation of basal epidermal cells, neoangiogenesis, and increased production of extracellular matrix proteins. However, there have been no studies to determine whether polyamines create a permissive stromal microenvironment needed for tumor growth, nor the signaling pathways that mediate the strong tumor promoting effects of polyamines. We postulate that polyamines promote skin tumorigenesis through activation of keratinocyte stem cells and dermal stromal cells and is mediated via polyamine-stimulation of the Akt signaling pathway, stabilization of beta-catenin, and activation of Tcf-dependent transcription. To investigate whether early in vivo changes in polyamine levels activate these signaling pathways to trigger the expansion of dormant, genetically altered epidermal cells into skin tumors, we propose using novel conditional mouse models to: 1. Identify target cells responsible for polyamine-promoted skin tumorigenesis by A. Assessing the effect of polyamines on stem cells B. Investigating the role of underlying stromal cells 2. Examine the involvement of the PI3K/Akt/mTOR pathway in the polyamine-activation of A. nontumor-bearing skin B. skin tumorigenesis C. skin vascularization. 3. Investigate the involvement of beta-catenin-Tcf-dependent transcription in the polyamine activation of keratinocytes and dermal fibroblasts. 4. Examine whether polyamines and activation of putative downstream effector pathways play a role in early human skin tumorigenesis. The overall goal is to identify the mechanism(s) by which elevated levels of polyamines alter environmental signals to trigger the proliferation of epidermal stem cells possessing genetic lesions in order to better design rational approaches to prevent cutaneous neoplasia.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA070739-11
Application #
7673454
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Poland, Alan P
Project Start
1996-08-01
Project End
2011-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
11
Fiscal Year
2009
Total Cost
$314,021
Indirect Cost
Name
Lankenau Institute for Medical Research
Department
Type
DUNS #
125797084
City
Wynnewood
State
PA
Country
United States
Zip Code
19096
Alexander, Eric T; Minton, Allyson; Peters, Molly C et al. (2017) A novel polyamine blockade therapy activates an anti-tumor immune response. Oncotarget 8:84140-84152
Hayes, Candace S; Shicora, Allyson C; Keough, Martin P et al. (2014) Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment. Cancer Immunol Res 2:274-85
Hayes, Candace S; DeFeo-Mattox, Karen; Woster, Patrick M et al. (2014) Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites. Amino Acids 46:543-52
Gerhart, Jacquelyn; Hayes, Candace; Scheinfeld, Victoria et al. (2012) Myo/Nog cells in normal, wounded and tumor-bearing skin. Exp Dermatol 21:466-8
Keough, Martin P; Hayes, Candace S; DeFeo, Karen et al. (2011) Elevated epidermal ornithine decarboxylase activity suppresses contact hypersensitivity. J Invest Dermatol 131:158-66
Hayes, Candace S; Defeo, Karen; Dang, Hong et al. (2011) A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development. Carcinogenesis 32:1340-8
Muller, Alexander J; DuHadaway, James B; Chang, Mee Young et al. (2010) Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion. Cancer Immunol Immunother 59:1655-63
Hogarty, Michael D; Norris, Murray D; Davis, Kimberly et al. (2008) ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. Cancer Res 68:9735-45
Wei, Gang; DeFeo, Karen; Hayes, Candace S et al. (2008) Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes. Cancer Res 68:2214-22
Gilmour, Susan K (2007) Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol 224:249-56

Showing the most recent 10 out of 23 publications